For: | Haloob I, de Zoysa JR. Metformin associated lactic acidosis in Auckland City Hospital 2005 to 2009. World J Nephrol 2016; 5(4): 367-371 [PMID: 27458565 DOI: 10.5527/wjn.v5.i4.367] |
---|---|
URL: | https://www.wjgnet.com/2220-6124/full/v5/i4/367.htm |
Number | Citing Articles |
1 |
José María Peña Porta, Hilda Mercedes Villafuerte Ledesma, Carmen Vicente de Vera Floristán, Ana Ferrer Dufol, Tránsito Salvador Gómez, Rafael Álvarez Lipe. Incidence, factors related to presentation, course and mortality of metformin-associated lactic acidosis in the healthcare area of a tertiary hospital. Nefrología (English Edition) 2019; 39(1): 35 doi: 10.1016/j.nefroe.2018.04.012
|
2 |
Mazumder Avijit, Singh Ashini. A Review on Metformin: Clinical Significance and Side Effects. Research Journal of Pharmacy and Technology 2021; : 6179 doi: 10.52711/0974-360X.2021.01070
|
3 |
Clara GOMES, Ana FERREIRA, Neuza SOARES, Vanessa CHAVES, Luís LEMOS, Sofia TAVARES, Marta COUTO. Metformin-associated lactic acidosis: underlying multiple myeloma. Gazzetta Medica Italiana Archivio per le Scienze Mediche 2022; 180(12) doi: 10.23736/S0393-3660.20.04320-X
|
4 |
Shoaib Ashraf, Prakash Upreti, Sunita Karki, Muhammad Khan, Rabih Nasr. Metformin-Associated Lactic Acidosis: A Case Report and Review. Cureus 2022; doi: 10.7759/cureus.24220
|
5 |
Bethan W. Hughes, Laurence A. Gray, Sally M. Bradberry, Euan A. Sandilands, Ruben H. Thanacoody, James M. Coulson. Metformin-associated lactic acidosis reported to the United Kingdom National Poisons Information Service (NPIS) between 2010 and 2019: a ten-year retrospective analysis. Clinical Toxicology 2023; 61(6): 445 doi: 10.1080/15563650.2023.2198667
|
6 |
Ravi Nistala, Ahmad Raja, Lakshmi Pulakat. mTORC1 inhibitors rapamycin and metformin affect cardiovascular markers differentially in ZDF rats. Canadian Journal of Physiology and Pharmacology 2017; 95(3): 281 doi: 10.1139/cjpp-2016-0567
|
7 |
Takako Mohri, Sawako Okamoto, Yuichi Nishioka, Tomoya Myojin, Shinichiro Kubo, Tsuneyuki Higashino, Sadanori Okada, Yasuhiro Akai, Tatsuya Noda, Hitoshi Ishii, Tomoaki Imamura. Risk of Lactic Acidosis in Hospitalized Diabetic Patients Prescribed Biguanides in Japan: A Retrospective Total-Population Cohort Study. International Journal of Environmental Research and Public Health 2023; 20(7): 5300 doi: 10.3390/ijerph20075300
|
8 |
Jean‐Daniel Lalau, Farshad Kajbaf, Alessandro Protti, Mette M. Christensen, Marc E. De Broe, Nicolas Wiernsperger. Metformin‐associated lactic acidosis (MALA): Moving towards a new paradigm. Diabetes, Obesity and Metabolism 2017; 19(11): 1502 doi: 10.1111/dom.12974
|
9 |
Takehide Umeda, Taro Minami, Keith Bartolomei, Eleanor Summerhill. Metformin-Associated Lactic Acidosis: A Case Report. Drug Safety - Case Reports 2018; 5(1) doi: 10.1007/s40800-018-0076-1
|
10 |
José María Peña Porta, Hilda Mercedes Villafuerte Ledesma, Carmen Vicente de Vera Floristán, Ana Ferrer Dufol, Tránsito Salvador Gómez, Rafael Álvarez Lipe. Incidencia, factores relacionados con la presentación, evolución y mortalidad de la acidosis láctica asociada a metformina en el área sanitaria de un hospital de tercer nivel. Nefrología 2019; 39(1): 35 doi: 10.1016/j.nefro.2018.04.007
|
11 |
A. Polach, D. Parcz, B. Ritter. Metforminassoziierte Laktatazidose (MALA) – eine fallbasierte Darstellung. Journal für Klinische Endokrinologie und Stoffwechsel 2018; 11(4): 127 doi: 10.1007/s41969-018-0048-1
|